Company Overview

Development Stage

  • Stage: IPO上市, 创业板, 深交所。
  • Ranking: Ranked #6 in Chaozhou by popularity
  • Honors: 2023中国广东企业500强 2023中国企业慈善公益500强 国家专利 企业技术中心 According to algorithm
  • News: 2026-01-27:凯普生物:预计2025年净亏损1.20亿元-1.95亿元。
  • Salary: 56% of positions earn 8-15K, In 2026 vs last yeardecreased by 4%.。Master's salary: ¥16.9K, Doctorate salary: ¥31.3K.
  • R&D: "医疗卫生/美容保健类" demand: 17.1%, "生物/制药/化工/环保类": 15.7%, "其他(研发和技术类)": 7.8%。
  • Recruiting: In 2026 vs 2025grew by 17%. Demand for highly educated talent: Master's: 28, Doctorate: 1.
  • Requirement: Education: 大专 leads with 34.5%. Experience: 不限 leads with 51.1%.
  • Region: Distributed across 11 regions, 广州: 26.2%, 潮州: 21.6%, 北京: 18.5%, 南京: 6.4%.

About the Company

[Summary] Provider of nucleic acid molecular diagnostics products

Hybribio (stock code: 300639), a manufacturer of nucleic acid molecular diagnostics products, is a good partner of clinical medical experts. The ten-year strategic plan of "Nucleic Acid 99 and Nucleic Acid 999" aims to achieve basically full coverage of domestic molecular diagnostics products and promote women and children's health in China.
Patent technology--"Human papillomavirus genotyping detection kit and gene chip preparation method thereof" won the 18th China Patent Gold Award, and the HPV series products with the patent gold award rank first in the national market share.

Hybribio Group continues to develop and grow. After twenty years of accumulation, it is based in Guangdong, develops across the country, and marches into the world. In Chaozhou and Guangzhou, national strategic emerging industry development projects--biochip research and development industrial bases have been established.
The company has established the Guangdong Provincial HPV-related Disease Molecular Diagnostics Engineering Technology Research and Development Center
Provincial Engineering Technology Center
Guangdong Provincial Enterprise Technology Center
Post-doctoral Scientific Research Workstation
Guangdong Provincial Academician and Expert Enterprise Workstation
Doctoral Scientific Research Workstation
Hybribio Hong Kong-Guangzhou Joint Laboratory

More than twenty Hybribio Medical Inspection Centers are distributed across the country, focusing on women and children's health and providing solutions and precise services for birth defect prevention and control testing.
In the new era and new wave, China's health is in action. Setting sail, Hybribio steps forward. With new exploration and new layout, it carries out medical health management, hospital cooperation and co-construction, and medical consortium construction to boost the big health industry.
Conscientious quality and scientific management are the foundation of Hybribio,
"Morality, wisdom, and perseverance" are the three treasures of Hybribio people,
If you have the boldness to be the first, are innovative, and forge ahead,
If you are a passionate hero with courage, ideals, and the willingness to challenge and dedicate to work,
Then please join Hybribio, expand new territories together,
Accept challenges, enjoy the joy of success,
Build the future together, and move forward.

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

Hybribio Financing History (1 rounds)

Manage
IPO上市
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Market: 创业板
  • Deal: 深交所

Hybribio How Fast Is Hiring Growing? (141 open positions)

Manage
Note: How fast is hiring at Guangdong Hybribio Biotech Co., Ltd. growing? Hybribio2025: 313 openings (down 27%), 2024: 428 openings (down 29%), 2023: 600 openings (down 34%), 2022: 910 openings (down 3%), 2021: 940 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Hybribio Master's Degree Job Demand Analysis

(More)
How fast is master's hiring at Guangdong Hybribio Biotech Co., Ltd. growing? HybribioMaster's recruitment over the years: 2025: 33 openings (up 106%), 2024: 16 openings (down 61%), 2023: 41 openings (down 32%), 2022: 60 openings (up 67%), 2021: 36 openings.

Hybribio Doctoral Degree Job Demand Analysis

(More)
-61%
Growth Rate
2026 vs 2025
  • 2025: Up 80%
  • 2024: Down 66%
  • 2023: Down 52%
  • 2022: Up 94%
Hybribio Doctoral Hiring by Year: 2026 — 11 fewer jobs than 2025
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at Guangdong Hybribio Biotech Co., Ltd. growing? HybribioDoctorate recruitment over the years: 2026: 7 openings (down 61%), 2025: 18 openings (up 80%), 2024: 10 openings (down 66%), 2023: 29 openings (down 52%), 2022: 60 openings (up 94%), 2021: 31 openings.

Hybribio R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at Guangdong Hybribio Biotech Co., Ltd.? Based on an analysis of Hybribio's job postings over the past year, "医疗卫生/美容保健类" demand: 17.1%, "生物/制药/化工/环保类": 15.7%, "其他(研发和技术类)": 7.8%, "计算机/网络/技术类": 7.3%, "美术/设计/创意类": 3.1%, "科研类": 2.5%. For reference only.

Hybribio — What Are the Salaries Like? (357 records)

Manage
salary range: 4.5K - 50K, 56% of roles pay ¥8-15K
Note: salary statistics are based on 357 salary records from the past year and depend on the job sample. For reference only.
How is the salary at Guangdong Hybribio Biotech Co., Ltd.?Hybribio56% of positions earn 8-15K, Fresh graduate salary: ¥10.2K。Chaozhou salary ranking top 5,销售类 average salary ¥12.1K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of Hybribio

(More)
Are salaries high at Guangdong Hybribio Biotech Co., Ltd.? We provide: 销售,市场,管培生,实验员,产品经理,策划,医师,推广,研发工程师,临床,省区经理,软件工程,bp,hr,应用工程师,内科,工艺工程,护士,检验,测序技术员. Click to view detailed salary analysis by job.

Hybribio Related Industry Tags

Job Category

  • 销售类
    27.4% of total 27.4%
  • 市场/公关/媒介类
    23.1% of total 23.1%
  • 医疗卫生/美容保健类
    15.4% of total 15.4%
  • 生物/制药/化工/环保类
    15.2% of total 15.2%

Education

  • 大专
    34.5% of total 34.5%
  • 本科
    25.6% of total 25.6%
  • 不限
    20.6% of total 20.6%
  • 硕士
    15.2% of total 15.2%

Experience

  • 不限
    51.1% of total 51.1%
  • 3-5年
    21.4% of total 21.4%
  • 1-3年
    18.5% of total 18.5%
  • 5-10年
    7.1% of total 7.1%
View Detailed Analysis

What does Guangdong Hybribio Biotech Co., Ltd. require? Who is Hybribio hiring? Hybribio recruitment: 销售类占比最多占27.4%,其次是市场/公关/媒介类占23.1%. What education can get in at Hybribio? 大专占比最多占34.5%,其次是本科占25.6%. High education required at Hybribio? 硕士占15.2%,博士占4%. Work experience required at Hybribio? 不限占比最多占51.1%,其次是3-5年占21.4%. Where are the job locations at Hybribio? 广州占比最多占26.2%,其次是潮州占21.6%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 64,650.0674万(元)
Legal Representative: 管乔中
Date Established:
Credit Code: 91445100751054069P
Registered Address: 广东省潮州市经济开发试验区北片高新区D5-3-3-4小区

Partners & Suppliers

为凯普生物提供HPV等核酸检测试剂临床试验 Source
供应商 诊断试剂企业
全国性医药流通企业,承担凯普诊断试剂的渠道分销 Source
合作客户 医药经销商
采购华大智造高通量测序仪,达成战略合作 Source
供应商 基因测序设备
为凯普生物提供核酸检测样本的冷链配送和样本中转服务 Source
供应商 冷链物流
联合推出女性宫颈癌筛查保险,凯普提供检测服务 Source
合作客户 健康保险

People who follow Hybribio also follow

Hybribio Competitors (Similar Companies)

“Electronic components and advanced technical ceramics industrial base”
营养食品 大健康 功能性食品 生产
“Huafeng Group is an integrated industrial and trading enterprise group”
糖果 宠物食品 薄荷糖 棒棒糖
印刷/包装 烫金 生产 工业
“Bring the digital world to every person, home, and organization, to bu”
物联网/IoT IT基础设施 服务外包 人力资源/HR外包
“Rapid test product R&D and manufacturer”
“钨及钨制品研发生产商”
胶水 聚氨酯 树脂 聚酯/PET
“National Key Leading Enterprise in Agricultural Industrialization”
火电 变电站 电力建设 热电联产
“A renowned enterprise in China's liver disease and anti-tumor fields”
“Manufacturer of mobile phone glass lens”
“Global leader in specialty glass and ceramic materials”

Discover Great Companies, Discover Great Clients

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates